Caroline Chandler, Flagship Project Manager, graduated from Colorado State University with a Bachelor of Science degree in sports medicine. Caroline shared her thoughts about her career and working at Flagship in this spotlight article.Early Cancer Treatment...
Cris Luengo, PhD, is Director of Image Analysis at Flagship Biosciences. Cris has a PhD in Image Analysis and an MSc in Applied Physics, both from Delft University of Technology, The Netherlands. Cris shared some experiences that led him to Flagship, as well as...
Westminster, CO — May 27, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced that Aymii Couzelis has been named to its executive team as Chief Information Officer. Aymii brings over 20 years of experience leading IT and product...
Mandy Bell is certified as a histotechnologist (HTL) by the American Society for Clinical Pathology (ASCP) and is the laboratory manager at Flagship Biosciences. Mandy received a BS in biology from Colorado State University. She said she has always wanted to be a...
Companies Now Delivering Regulatory Services to the Pharmaceutical IndustryWestminster, CO — April 30, 2020 — Flagship Biosciences, providers of expert tissue data insights, today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory...
Sara Wells is a histotechnician at Flagship Biosciences. She recently shared some background for a spotlight article, as well as an update on working during the COVID-19 outbreak. Sara received her BS in Biotechnology from Kent State University. She says she has...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
PUBLICATIONS
ABSTRACT In vitro diagnostic (IVD) approvals of qualitative immunohistochemical (IHC) assays offer unique patient selection strategies by equipping pathologists with new tools to assess tumor status including tumor immune landscape. PD-L1/PD-1 checkpoint therapies...
Key Takeaways Successful pathology AI does not replace, but assist pathologists in high-complexity tissue analysis Transparency and control is retained in a pathologist-centric AI-based system Pathology AI enables cost effective healthcare by testing for multiple...
Key takeaways Building Predictive Models of Clinical Outcomes in Immune Oncology Using Computational Tissue Analysis Scorecards The spatial location of PD-L1 expression can identify patients who will likely respond to anti-PD-1/PD-L1 therapy Flagship’s unique spatial...
EVENTS
Join Flagship for the Oncology Companion Diagnostics Xchange at hubXchange West. February 6-9, 2023. Attending hubXchange West? Meet with us to discuss how we can partner with you for end-to-end support of your immunotherapy research and development program....
Visit Flagship at the SB-IO Summit.January 17-19, 2023. Attending the inaugural SB-IO Summit? Stop by our booth to discuss how we can partner with you for end-to-end support of your immunotherapy research and development program. AI-powered digital pathology solutions...
Visit Flagship at ASH | Booth #1015. December 10-13, 2022. Attending ASH 2022? Stop by our booth to discuss how we can partner with you for end-to-end biomarker support. Discover our recently expanded services menu and pick up a map of our favorite New Orleans...